Advances in Pain Management: Exploring Molecular Mechanisms and Novel Therapies

Dear Colleagues,

Pain is now recognized as a complex pathological state involving sophisticated interactions between peripheral sensory pathways, central nervous system processing, immune activation, and psychological factors. Over the past decade, there have been remarkable advancements in pain research, particularly in the areas of neuroinflammation, sensory signaling, and genetic susceptibility.

This Special Issue provides an opportunity to bring together cutting-edge research that deepens our understanding of the molecular mechanisms underlying pain while also highlighting promising therapeutic approaches aimed at improving patient outcomes. Research areas may include, but are not limited to, the following:

• Molecular and cellular mechanisms of pain;
• Genetic and epigenetic factors in pain susceptibility and chronic pain conditions;
• Neuroimmune interactions in pain modulation;
• Emerging pharmacological targets for pain relief;
• Novel pain therapies, including gene therapy, stem cell therapy, and biologics;
• Innovative drug delivery systems for targeted pain relief.

We look forward to receiving your contributions and collaborating to advance the field of pain management.

Dr. Christopher Robinson
Guest Editor

Dr. Samuel Ang
Dr. Rodrigo Diez-Tafur
Guest Editor Assistants

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.